Investment Q&A

Q: What would explain Boeing's large negative PB ratio in your company report?

Q: My understanding that there might be hundreds of companies on the Venture and CSE exchanges involved with the BridgeMark Group. Can you comment it seems both exchanges have almost zero monitoring in terms of investor protection. The news was general downplayed and many of the affected companies named continue to attract investors.

“Based on evidence obtained in respect of the other seven issuers (companies), Staff are concerned that members of the BridgeMark Group also executed the scheme with those issuers,” stated BCSC. The other seven companies include: Kootenay Zinc Corp.; Affinor Growers Inc.; Beleave Inc.; Liht Cannabis Corp. (formerly known as Marapharm Ventures Inc.); PreveCeutical Medical Inc.; Speakeasy Cannabis Club Ltd.; and Abattis Bioceuticals Corp.

To date, BCSC has temporarily banned BridgeMark members from buying or selling shares of the 11 companies. It has also blocked all CSE-listed companies from using the consultant exemption to sell shares to BridgeMark members.

Q: My daughter has a business that develops websites for small businesses. She sees most of her clients using SurveyMonkey. What is your opinion regarding SurveyMonkey as an investment?

Q: Do you still like Brick and if yes are we close to a good entry price.?

Q: Carmanah is selling its Sabik assets and will end up with net cash of about CAD $118 million. This for a company with a current market cap of only CAD $65 million. Are there significant residual assets after the Sabik sale? On its face it looks like this is an opportunity to buy a dollar for 55 cents and get the remaining business for free.

Q: Which technology shares would be the most stable and promising from the ones listed?
Thank you, TEAM!

Q: What are your thoughts on NXR as a hold for the next 2 - 3 years.

Brenda

Q: Hi there
Can you suggest 3 companies outside Canada for good dividend and some growth something reasonably safe ideal dividend in the 4% range
Sam

Q: I bought back in to tsgi around 23.00, took a large position , good news on nba, but stock csnnot catch a bid even in an up market, so is something going on i am missing, is it their debt or something else, tax loss selling company seems to be doing everything right. Dave

Q: On my US portfolio I have: VGG @ 33%, HXQ @ 25%, HXS @ 25% and a combination of IWO,XSU, XMH @ 17%. I am trying to minimize taxes (dividends & form 1135) while maintaining US exposure/growth. Would you comment on this set up? Thank you for your service.

Q: Hi 5i!
Pretty tepid reaction to yesterday's news. Even on today's broad market bounce, the stock doesn't seem to get any traction, holding barely into positive territory. And after a 50%+ fall from its june high, what are your thoughts on such negativity on TSGI? Has the fundamentals changes this much in 5-6 months? In hindsight, this feels like such a fad...

Anyways, thanks for 2018 and a Happy Holidays to all of you folks at 5i !!!

Q: Hi, I currently own Et ,Otex ,Pho, Shop, SYZ, and i’am thinking of selling two or three and buying Csu.
I will be doing this for a more stable and overall better portfolio if or when we get a further market downturn.
Is my strategy sound? And which two or three would you sell? I would also be open to sell four and keep two of the best if this works.
Thanks

Q: I just read about TENCENT's new music streaming venture. Could I get your opinion please and your opinion on TCEHY.

Q: Hi
What would the BE portfolio performance be without CSU Constellation Software be as holding over time? What if it was a company listed outside of Canada. With this thought, are there any companies outside of Canada that you would consider the same caliber as CSU (same sector is not important to me)? Sorry for the outside of Canada question but I am hoping to add some diversification over the next few years.
Thank you
J

Q: I was wondering if you could give me your thoughts on this stock which is in its very early stages. At what stage would it be wise to consider as an investment or is it something 5 I would be interested in?
Thank you for your time.

Q: Hi Sir
I have selected few dividend paying stocks i.e kmp.un,eif,rei.un,pki,ipl,trp,t
Can these stocks sustain dividend, which stocks are strong to hold their price in 2019
Can you name other dividend paying stocks
Thanks

Q: Good day i have vet in my rsp for the great dividends they pay .How do you view this company as far as being able to continue with there payouts,they are getting beat up like all the others,i appreciate your opinions,thanks Norm

Q: Hi, most of my portfolio is trying to hang in with such a volatile market, but these two companies are killing me.
I see vet is now over 9% dividend which I like, but also know nothing good comes from it.
Is it time to raise the white flag to fossil fuels and go totally renewable, or would I probably be selling at the low?
I have to hand it to the environmentalist and protesters they are doing a great job against the oil companies.
Could you give me two of your favourites for renewables.
Thanks

Q: I plan on selling VET this week and yet its share price keeps on falling. At today close I'm down about 25%. I was planning to let it go at about 22 to 23%.

Should I just sell VET at whatever price it opens tomorrow? Or you believe the majority of the tax loss selling are over and there is a chance that there could be a slight rebound. Please advise.

Q: This is a comment more than a question. By a review of the questions commonly asked on it appears that too many of us are caught up in the day to day and , week to week volatility. If the investment thesis has not changed and it still seems undervalued I see no reason why one should sell a stock based on its current trading price. For example, I own a large position in Questor and the share price has been on a rollercoaster. I stuck it out because the long term fundamentals had not changed and it is up about 15% on the year. I actually believe the fundamentals have improved materially throughout the year but one would not conclude that by examining the price chart alone.